alkenes has been researched along with thyroxine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, LL; Fallon, HJ; Lamb, RG | 1 |
Edwards, KD | 1 |
Müller, G | 1 |
Ardecky, RJ; Boehm, MF; Chen, JH; D'Arrigo, J; Grese, TA; Karanewsky, DS; Leibowitz, MD; Liu, S; Mais, DA; Mapes, CM; Michellys, PY; Montrose-Rafizadeh, C; Ogilvie, KM; Reifel-Miller, A; Rungta, D; Thompson, AW; Tyhonas, JS | 1 |
Gonzalez, FJ; Inotsume, Y; Ito, Y; Kamijima, M; Li, CM; Nakajima, T; Taya, K; Watanabe, G; Yamanoshita, O; Yanagiba, Y; Zhang, SY | 1 |
3 review(s) available for alkenes and thyroxine
Article | Year |
---|---|
A review of studies on the mode of action of clofibrate and betabenzalbutyrate.
Topics: Acyltransferases; Adenylyl Cyclase Inhibitors; Adipose Tissue; Albumins; Alkenes; Animals; Butyrates; Cholesterol; Clofibrate; Coenzyme A; Glycerol; Glycerophosphates; Ligases; Lipid Metabolism; Liver; Male; Microsomes, Liver; Protein Binding; Rats; Thyroxine; Triglycerides | 1972 |
Antilipaemic drugs and nephrotic hyperlipidaemia.
Topics: Alkenes; Animals; Blood Protein Disorders; Blood Proteins; Butyrates; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Lipids; Lipoproteins; Nephrotic Syndrome; Phospholipids; Thyroxine; Tryptophan | 1972 |
[Therapy of hyperlipidemia].
Topics: Alkenes; Animals; Arteriosclerosis; Cholesterol; Clofibrate; Diet Therapy; Fatty Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Oxidation-Reduction; Rats; Thyroxine | 1971 |
2 other study(ies) available for alkenes and thyroxine
Article | Year |
---|---|
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids.
Topics: Alkenes; Animals; Benzene Derivatives; Caprylates; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Drug Synergism; Hypoglycemic Agents; Male; Mice; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Thyroxine; Transcription Factors; Transfection; Triglycerides | 2003 |
Styrene trimer may increase thyroid hormone levels via down-regulation of the aryl hydrocarbon receptor (AhR) target gene UDP-glucuronosyltransferase.
Topics: Alkenes; Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Cytochrome P-450 CYP1A1; Cytochrome P450 Family 2; Dioxins; Down-Regulation; Gene Expression; Glucuronosyltransferase; Mice; Mice, Knockout; Molecular Structure; Polystyrenes; Receptors, Aryl Hydrocarbon; Reverse Transcriptase Polymerase Chain Reaction; Steroid Hydroxylases; Terphenyl Compounds; Thyroid Hormones; Thyroxine | 2008 |